• BH3-Mimetics Reveal Glioblastoma’s Apoptotic Vulnerability

  2026-08-16

  Koessinger et al. show that glioblastoma, including patient-derived stem-like populations, is unusually dependent on the anti-apoptotic proteins BCL-xL and MCL-1. Their study links this apoptotic priming to therapeutic sensitivity and demonstrates that sequential inhibition of both survival pathways can produce strong antitumor responses in vivo without overt toxicity.

• Miltefosine Workflows for PI3K/Akt and Neutrophils

  2026-08-15

  Miltefosine supports two experimentally distinct use cases: rapid PI3K/Akt pathway interrogation in cancer models and longer-horizon studies of neutrophil differentiation in leukopenia. This guide converts those findings into practical dosing, readout, troubleshooting, and pathway-validation workflows.

• Mubritinib (TAK 165): OXPHOS Assay Workflows

  2026-08-15

  A practical guide to using Mubritinib (TAK 165) for mitochondrial complex I, AML, and KSHV-positive PEL research. It connects dose selection, respiratory measurements, viability readouts, and troubleshooting to a reference study that demonstrates why functional OXPHOS assays outperform target assumptions alone.

• Everolimus (RAD001) Assay Workflow Guide

  2026-08-14

  Build more informative mTOR-inhibition experiments with Everolimus (RAD001), from solvent handling and dose–response design to paired viability and apoptosis measurements. This workflow separates growth arrest from cell killing, helping cancer researchers interpret results in pancreatic, lung, renal, and ovarian models with greater confidence.

• Cytarabine (AraC): Leukemia Assay Workflows

  2026-08-14

  Build more informative Cytarabine (AraC) experiments by pairing dose–response measurements with dCK, DNA damage, p53, and caspase readouts. The workflow also shows how to distinguish Cytarabine-driven apoptosis from RIPK3-linked necroptosis signals described in virus research.

• WP1066: A Context-Aware JAK2/STAT3 Assay Guide

  2026-08-13

  WP1066 is a cell-permeable JAK2/STAT3 inhibitor for dissecting phosphorylation-dependent signaling, cancer phenotypes, and context-specific macrophage biology. This guide connects product pharmacology with an infectious bone-regeneration study while defining practical assay boundaries.

• Hoechst 33342: A Quantitative Nuclear Readout

  2026-08-13

  Hoechst 33342 nuclear stain provides a practical bridge between live-cell imaging, fixed-cell analysis, and flow cytometry in fibroblast senescence research. This guide explains how to use nuclear labeling as an assay-quality and normalization tool when studying pterostilbene, mitochondrial quality, and dermal aging.

• Pentoxifylline Downregulates ICAM-1 in Monocytes

  2026-08-12

  The 1997 reference study showed that Pentoxifylline reduces ICAM-1 expression in human monocytes at both the protein and mRNA levels after oral exposure in healthy volunteers and after direct in vitro treatment. Its TNF-α reversal and neutralization experiments connected this effect to suppression of TNF-α signaling, providing a mechanistic basis for studying this phosphodiesterase inhibitor as an anti-inflammatory compound.

• WP1066: JAK2/STAT3 Inhibitor Workflows

  2026-08-12

  WP1066 provides a cell-permeable way to test JAK2/STAT3 dependence in cancer-cell proliferation, AML models, and renal carcinoma systems. This workflow guide also explains how to use the inhibitor as a mechanistic control when studying regenerative scaffolds that require, rather than suppress, JAK2-STAT3 signaling.

• Sulfur Supply Delays Soybean Nodule Senescence

  2026-08-11

  This study identifies sulfur delivery into the soybean symbiosome as a regulatory bottleneck in nodule longevity. Genetic evidence links SULTR-mediated sulfur transport to glutathione maintenance and reactive nitrogen species control, suggesting strategies to preserve symbiotic nitrogen fixation under high-nitrogen stress.

• Patient-Derived Gastric Cancer Assembloid Insights

  2026-08-10

  Shapira-Netanelov and colleagues developed gastric cancer assembloids that combine patient-matched tumor organoids with separately expanded stromal cell subpopulations. The model reproduced tumor-associated heterogeneity, altered transcriptomic states and drug responses relative to organoid monocultures, providing a more informative framework for studying resistance and individualized treatment strategies.

• Staurosporine Workflows for Kinase and Cancer Research

  2026-08-09

  Staurosporine combines strong apoptosis-inducing activity with broad kinase pathway coverage, making it useful for viability, signaling, motility, and angiogenesis experiments. This guide emphasizes controlled DMSO handling, orthogonal readouts, and safeguards against mistaking cytotoxicity for pathway-specific inhibition.

• CHIR 99021 Trihydrochloride: GSK-3 Workflows

  2026-08-08

  CHIR 99021 trihydrochloride provides a tunable GSK-3 inhibition strategy for organoid expansion, stem cell fate studies, and metabolic research. This guide translates recent intestinal organoid findings into practical dosing, assay design, and troubleshooting decisions while separating evidence-backed specifications from workflow recommendations.

• Shenqi Fuzheng Injection in Glioma: SRC/PI3K/AKT

  2026-08-07

  This 2024 Journal of Ethnopharmacology study combines network pharmacology with cellular and mouse experiments to investigate how Shenqi Fuzheng injection affects glioma proliferation and migration. Its central contribution is the identification of SRC/PI3K/AKT signaling as a mechanistic axis associated with SFI-mediated cell-cycle arrest, reduced migration, and slower tumor growth.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Bioma

  2026-08-07

  Unlock next-level sensitivity in immunofluorescence with the FITC Goat Anti-Rabbit IgG (H+L) Antibody. Learn how tailored workflows and troubleshooting strategies can drive robust, reproducible biomarker discovery—especially in challenging applications like early diabetic nephropathy monitoring.

455 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page